Intrathecal cyclosporin prolongs survival of late-stage ALS mice (Q43543805)

24 November 2017

Intrathecal cyclosporin prolongs survival of late-stage ALS mice (English)

1 reference

amyotrophic lateral sclerosis

24 November 2017

1 reference

2

1 reference

24 November 2017

M Keep

1

1 reference

24 November 2017

K S Fong

series ordinal

3

1 reference

24 November 2017

K Csiszar

series ordinal

4

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

24 November 2017

5

1 reference

based on heuristic

inferred from page(s)

published in

Brain Research

1 reference

24 November 2017

894

1 reference

24 November 2017

2

1 reference

24 November 2017

327-331

1 reference

Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Permeability of the blood-brain barrier to the immunosuppressive cyclic peptide cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Elevated "hydroxyl radical" generation in vivo in an animal model of amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Copper,zinc superoxide dismutase is primarily a cytosolic protein in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Carboxyfullerenes as neuroprotective agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Cyclosporin A, but not FK 506, protects mitochondria and neurons against hypoglycemic damage and implicates the mitochondrial permeability transition in cell death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Inhibition of ICE slows ALS in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Transgenic-mouse model of amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Transgenic animal models of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

The copper chelator d-penicillamine delays onset of disease and extends survival in a transgenic mouse model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

The immunosuppressants cyclosporin A and FK506 equally ameliorate brain damage due to 30-min middle cerebral artery occlusion in hyperglycemic rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Molecular cloning and regional distribution of rat brain cyclophilin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

The role of immunophilins in mutant superoxide dismutase-1linked familial amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Concentrations of cyclosporin A and its metabolites in human tissues postmortem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Amelioration by cyclosporin A of brain damage following 5 or 10 min of ischemia in rats subjected to preischemic hyperglycemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

The roles of free radicals in amyotrophic lateral sclerosis: reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

No benefit of dietary restriction on disease onset or progression in amyotrophic lateral sclerosis Cu/Zn-superoxide dismutase mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Regulation of neuronal Bcl2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Cytochrome c: can't live with it--can't live without it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Continuous infusion of cyclosporin A postinjury significantly ameliorates cortical damage following traumatic brain injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Immunointervention with cyclosporin A in autoimmune neurological disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

P-glycoprotein-mediated efflux transport of anticancer drugs at the blood-brain barrier.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Amelioration by cyclosporin A of brain damage in transient forebrain ischemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Cyclosporin A dramatically ameliorates CA1 hippocampal damage following transient forebrain ischaemia in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Motor neuron disease (amyotrophic lateral sclerosis).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Posttreatment with the immunosuppressant cyclosporin A in transient focal ischemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Mitochondrial permeability transition in the central nervous system: induction by calcium cycling-dependent and -independent pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902012-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-8993(01)02012-1

1 reference

24 November 2017

1 reference